Danya Cebus: Do Dividend and Buyback Make Sense in a Year When Cash Actually Shrinks
The main article argued that Danya Cebus has to turn backlog into cash, not just into reported profit. This follow-up isolates the 2025 capital-allocation paradox: negative operating cash flow, Blue Line equity funding and an equity raise, alongside a steady dividend, an extra post-balance-sheet dividend and a newly approved buyback.
What This Follow-up Is Isolating
The main article argued that the key question for Danya Cebus is not just how much backlog it carries, but how much of that backlog actually turns into cash. This continuation starts from that same point and isolates one specific management choice: to keep returning capital, and even add a buyback, in a year when the cash pile did not build but shrank.
This is not really a legal-distribution debate. On paper, Danya Cebus has room. At year-end 2025 it had about NIS 292 million of distributable profits, and in the buyback filing the board explained that even after the post-balance-sheet NIS 40 million dividend and a full NIS 50 million buyback, distributable profits would still stand at roughly NIS 202 million. The narrower question is different: what does the company’s all-in cash flexibility look like after dividends, investments, repayments and project-equity needs?
On that test, 2025 does not look like a year of surplus cash. Net income was NIS 167.2 million, but operating cash flow turned to negative NIS 109.3 million, investing cash flow was negative NIS 157.4 million, and cash and cash equivalents fell from NIS 728.6 million at the start of the year to NIS 384.3 million at the end. Inside that same year the company paid NIS 160 million of dividends, completed an equity raise that brought in NIS 149.7 million net, and then approved both another dividend and a buyback after the balance-sheet date.
That is the paradox. Danya Cebus is not allocating capital out of a year in which cash accumulated. It is allocating capital out of a year in which cash was absorbed by execution.
The Capital-allocation Picture in Numbers
| Item | Amount, NIS millions | Why it matters |
|---|---|---|
| 2025 net income | 167.2 | The accounting earnings base behind the distribution case |
| Dividends paid in 2025 | 160.0 | Almost the entire annual profit already left in cash |
| 2025 operating cash flow | -109.3 | The business itself did not produce cash in the year, it consumed it |
| Investments and loans to investees, net | -110.5 | Capital already tied to projects, led by the Blue Line |
| Net proceeds from share issuance | 149.7 | Flexibility depended on fresh equity, not only on internally generated cash |
| Post-balance-sheet dividend approval | 40.0 | Another cash return already added to the 2026 starting point |
| Approved buyback ceiling | up to 50.0 | An extra layer of capital return on top of the dividend |
The chart highlights something that is easy to miss on a quick read. The formal dividend policy talks about an annual payout of 35% of net income, but the actual distribution history in 2024 and 2025 looks much more like a quarterly NIS 40 million anchor. In 2024 the company paid NIS 160 million against NIS 173.6 million of net income. In 2025 it again paid NIS 160 million against NIS 167.2 million of net income. That is not what a bare 35% formula looks like in practice. It looks like a deliberate choice to preserve a much heavier cash-distribution cadence.
Against that backdrop, operating cash flow moved from a positive NIS 255.5 million in 2024 to negative NIS 109.3 million in 2025. So in the same year in which the company kept a nearly fixed distribution pace, the operating cash engine went the other way.
Where the Cash Actually Went
Management explains the negative operating cash flow through very large execution volumes in the last quarters of the year, which at this stage hit cash outflows more heavily than cash collections, alongside excess collections in the prior period. That is a plausible explanation, but it matters to unpack the numbers underneath it.
The key line in the cash-flow statement is the NIS 427.1 million increase in customers and contract assets. That is exactly the bottleneck already flagged in the main article: the company is growing, signing and executing, but a large part of the activity is still sitting in working capital rather than in the bank account. Suppliers and subcontractors added NIS 40.1 million, other payables added NIS 53.5 million, and provisions added NIS 17.2 million, but that was nowhere near enough to offset the working-capital drag.
Investing cash flow was not a side issue either. The company spent NIS 78.0 million on property, plant and equipment, and the line for investments and loans to investees, net, stood at negative NIS 110.5 million. During the year the company extended roughly NIS 115 million of financing to an investee as part of the equity required for the Blue Line project in Jerusalem. That matters because it means part of what may look like general liquidity is already being pulled into project-equity needs.
The liquidity disclosure also needs a careful read. The company presents cash, restricted deposits and marketable collateral of roughly NIS 592 million as of December 31, 2025. That is a healthy-looking number, but it is not the same thing as fully free cash. The fact that the label itself includes restricted deposits and marketable collateral means not all of it has the same quality for dividends or buybacks.
This is the core distinction between distributable profits and real cash flexibility. On the accounting test, Danya Cebus has room. On the all-in cash test, 2025 looks like a year in which the balance sheet had to support operations, projects and repayments, not a year in which effortless surplus cash emerged.
The Buyback Is a Strong Signal, but Not an Answer to the Main Problem
The buyback program was approved by the board on March 1, 2026, is scheduled to start on March 2, 2026 and run through March 1, 2027, and carries an aggregate ceiling of up to NIS 50 million. Funding is expected to come from the company’s own sources, purchases can be executed on exchange or off exchange, and the company is under no obligation to execute the full program.
Those caveats matter, but they also clarify what the program does say. It is a signal. The board is trying to tell the market that the share price is attractive, that excess capital has a valid alternative use, and that in its view there is no reasonable concern about meeting obligations or financial covenants. In other words, this is not a capital return the company is forced into. It is a choice.
But that signal does not solve the bottleneck exposed by the 2025 accounts. A buyback does not release customers and contract assets into cash. It does not fund the equity required for the Blue Line project. It also does not erase the fact that 2025 already included a NIS 149.7 million equity raise. So even if the program itself is not binding, the approval still says that management is willing to add an equity-return layer on top of the ordinary dividend at a moment when cash generation has not yet proven it is back to normal.
The subtle issue here is sequencing. If 2025 had ended with strong operating cash flow, rising cash balances and no equity raise, it would have been much easier to read the buyback as classic capital allocation. In a year with negative operating cash flow, higher investee funding needs and a shrinking cash balance, the buyback becomes less a question of “is it allowed” and more a question of “is this the right timing”.
The Strongest Counter-thesis
To be fair, the board does have a serious counter-argument. Consolidated backlog stands at about NIS 22.0 billion, and after the balance-sheet date the company signed additional projects totaling NIS 2.399 billion. In other words, this does not look like a business facing a lack of work. The company also argues that the 2025 cash weakness mainly reflects timing between execution and collections rather than a broad collapse in profitability, and it still ended the year with total liquidity of roughly NIS 592 million.
So the reasonable counter-thesis is that 2025 was mainly a timing year: heavy execution, heavy working-capital pull, collections to come later. If that is the right reading, then a NIS 40 million post-balance-sheet dividend and even a partial buyback may not look aggressive in hindsight.
But this is exactly where the burden of proof shifts. Once a company keeps distributing and also approves a buyback inside a cash-transition year, 2026 has to do more than show acceptable profit and a large backlog. It has to show that the work is finally turning into cash.
What Has to Happen Next
The first thing to watch is working-capital release. If customers and contract assets keep rising through 2026, the “timing only” explanation will weaken. If that line starts to reverse and operating cash flow turns supportive again, it will be much easier to justify the choice to preserve a high dividend pace and open a buyback program.
The second issue is project-equity consumption in infrastructure and concession activity. The Blue Line already required roughly NIS 115 million of financing to an investee in 2025 as part of the equity needed for the project. If similar demands continue at a high pace, it will become clear that a meaningful part of the company’s liquidity is not really available for shareholder returns.
The third issue is the real funding source of distributions. If the company can fund dividends, and perhaps part of the buyback, out of cash generated by operations, that will be a strong validation of the board’s stance. If it instead needs fresh equity again, or keeps relying on new capital and short-term funding rather than collections, the 2026 capital-allocation choice will look less like discipline and more like expensive signaling.
Bottom Line
The real story here is not a shortage of distributable profits. It is the order of priorities. Danya Cebus ended 2025 with profit, with a strong backlog and with meaningful liquidity, but also with negative operating cash flow, a sharp fall in cash, a material Blue Line funding need and an equity raise that restored flexibility to the balance sheet. Inside that picture it chose not only to preserve an annual NIS 160 million dividend pace, but also to approve another NIS 40 million dividend and a buyback of up to NIS 50 million.
That does not automatically make the decision wrong. But it does make the capital allocation more demanding than the headline of “distributable profits” suggests. From here, the key test is not whether the authorization exists, but whether the next few quarters prove that cash starts moving in the same direction as backlog and profit. If that happens, the buyback will look like disciplined capital deployment. If not, it will look like one more layer of distribution introduced too early.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.